Understanding Avoidance in Anxiety

This study is looking for people aged 22 to 55 with anxiety to help us understand avoidance behavior. We're using special behavioral tasks with brain imaging (fMRI) to see how your brain works during these tasks. After each brain scan, you'll complete weekly surveys for one month about your real-world avoidance. We want to see if changes in how you avoid things in the lab tasks affect your everyday avoidance. The goal is to learn more about why people with anxiety avoid certain situations and how this relates to brain activity. We are aiming to enroll 163 participants.

Study design
This is an interventional study with an estimated 163 participants. It is not specified if it is randomized or blinded.
What's involved
You will complete behavioral tasks during three separate fMRI scanning sessions. After each session, you will complete one week of self-reported avoidance surveys for a total of four weeks of surveys.
Compensation
Not stated in the trial record.
Follow-up
Your avoidance behavior will be measured at baseline, and then weekly for four weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07203027

Quantifying Multi-step Avoidance in Anxiety

Not Yet Recruiting
NAAges 22–55InterventionalBasic science
Emory University
~163 participants
Updated 2026-05-07 on ClinicalTrials.gov
What's tested:Behavioral Tasks with imaging

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Ecological momentary assessment (EMA)
Measured over Baseline, week 1, week 2, week 3, and week 4
+2 more outcomes measured
Anxiety
Anxiety Disorders

NCT07203027

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Emory College

    Atlanta, Georgiano site contact published

  • Facility for Education and Research in Neuroscience (FERN)

    Atlanta, Georgiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Vanessa M Brown, PhD · PRINCIPAL_INVESTIGATOR · Emory University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ability to comprehend written and spoken English
Ability to provide informed consent
Estimated intelligence quotient (IQ) \>70.
Clinically significant anxiety symptoms (scoring above clinical cutoff on at least one Inventory of Depression and Anxiety Symptoms (IDAS) anxiety-related subscale and/or OASIS total)
Significant anxiety-related avoidance (scoring 2 or above on a 0-4 scale, indicating at least "occasional" avoidance) on the avoidance-related question on the Overall Anxiety Severity and Impairment Scale (OASIS)
Functional impairment, defined as at least moderate impairment in one WHO Disability Assessment Schedule (WHODAS 2.0) domain related to anxiety.

Exclusion

Individuals younger than 22 or older than 55,
Individuals with an IQ \< 70,
A lifetime history of neurological disorder or brain damage,
Contraindications for undergoing MRI scanning,
A lifetime history or diagnosis of psychosis or bipolar disorder,
Current substance use intoxication or withdrawal,
Severe risk of suicide, or
Recent (\<3 months) changes in psychotropic medicine or psychotherapy treatment,
Ineligible at the PI's discretion, are excluded.
  • Ecological momentary assessment (EMA)Baseline, week 1, week 2, week 3, and week 4

    Participants will complete one week of ecological momentary assessment (EMA) to assess real-world avoidance behaviors after each of the scanning visits. The proportion of assessments where participants report engaging in avoidance behavior in the last hour will be assessed. Changes in the proportion of assessments where avoidance is reported will be used to measure changes in avoidance severity.

  • Avoidance Severity Based on Location EntropyBaseline, week 1, week 2, week 3, and week 4

    Avoidance severity will be assessed using passive sensing of daily location patterns after each fMRI scanning visit. Participants will complete one week of passive sensing of location (using phone-based GPS measures) to assess real-world avoidance behaviors after each of the scanning visits. Changes in location entropy, representing the distribution of unique locations visited per day, will be used to measure changes in avoidance severity. Lower entropy values will indicate greater avoidance severity, while higher values will indicate less avoidance.

  • Change in Location EntropyBaseline, week 1, week 2, week 3, and week 4

    Location entropy, defined as the distribution of unique locations visited per day, will be measured using one week of passive phone-based GPS monitoring after each fMRI scanning visit. This measure reflects variability in movement patterns and real-world avoidance behaviors.